Clinical Report: Patient-Centered Digital Decision Support for Antiobesity Treatments
Overview
This report evaluates a digital patient decision aid (PDA) designed to assist adults in Taiwan in selecting antiobesity medications (AOMs). The study highlights the importance of shared decision-making in obesity treatment and the need for tailored decision support tools to improve patient engagement and outcomes.
Background
Obesity is a significant global health issue, with rising prevalence rates leading to increased risks of chronic diseases. In Taiwan, the prevalence of overweight and obesity has surpassed 50% among adults, necessitating effective weight management strategies. Shared decision-making is crucial in obesity care, particularly when selecting among various AOMs, as these decisions should align with individual patient values and preferences.
Data Highlights
No numerical or trial data available in the source material.
Key Findings
The prevalence of overweight and obesity in Taiwan rose from 32.7% in 1993-1996 to 50.8% in 2022.
Shared decision-making (SDM) enhances patient engagement and improves treatment outcomes in obesity care.
Existing patient decision aids primarily target surgical options, leaving a gap for adults considering AOMs.
A human-centered design process was used to develop a digital PDA tailored for AOMs in Taiwanese clinical settings.
Unmet information needs and weight stigma can hinder patient engagement with healthcare providers.
Clinical Implications
Healthcare professionals should consider implementing digital PDAs to facilitate shared decision-making in obesity treatment. These tools can help patients better understand their options and align treatment choices with their personal values, ultimately leading to improved adherence and outcomes.
Conclusion
The development of a patient-centered digital decision aid represents a significant step towards enhancing shared decision-making in obesity treatment. By addressing the specific needs of patients considering AOMs, this tool aims to improve engagement and treatment satisfaction.
